Goldman Sachs Group Inc Dare Bioscience, Inc. Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding DARE
# of Institutions
25Shares Held
7.23MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$11 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$3.29 Million0.0% of portfolio
-
Amh Equity LTD924KShares$3.02 Million0.44% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny779KShares$2.55 Million0.0% of portfolio
-
State Street Corp Boston, MA282KShares$922,8260.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $277M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...